BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 22610277)

  • 1. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.
    Tenbaum SP; Ordóñez-Morán P; Puig I; Chicote I; Arqués O; Landolfi S; Fernández Y; Herance JR; Gispert JD; Mendizabal L; Aguilar S; Ramón y Cajal S; Schwartz S; Vivancos A; Espín E; Rojas S; Baselga J; Tabernero J; Muñoz A; Palmer HG
    Nat Med; 2012 Jun; 18(6):892-901. PubMed ID: 22610277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
    Yang JY; Chang CJ; Xia W; Wang Y; Wong KK; Engelman JA; Du Y; Andreeff M; Hortobagyi GN; Hung MC
    Cancer Res; 2010 Jun; 70(11):4709-18. PubMed ID: 20484037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3a and β-catenin co-localization: double trouble in colon cancer?
    Yan Y; Lackner MR
    Nat Med; 2012 Jun; 18(6):854-6. PubMed ID: 22673992
    [No Abstract]   [Full Text] [Related]  

  • 5. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
    Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US
    PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling.
    Ormanns S; Neumann J; Horst D; Kirchner T; Jung A
    Oncotarget; 2014 May; 5(10):2999-3011. PubMed ID: 24930890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
    Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
    Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.
    Lee G; Goretsky T; Managlia E; Dirisina R; Singh AP; Brown JB; May R; Yang GY; Ragheb JW; Evers BM; Weber CR; Turner JR; He XC; Katzman RB; Li L; Barrett TA
    Gastroenterology; 2010 Sep; 139(3):869-81, 881.e1-9. PubMed ID: 20580720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear accumulation of β-catenin and forkhead box O3a in colon cancer: Dangerous liaison.
    Link W
    World J Biol Chem; 2012 Sep; 3(9):175-9. PubMed ID: 23024836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
    J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
    Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.
    Zeng B; Li Y; Niu B; Wang X; Cheng Y; Zhou Z; You T; Liu Y; Wang H; Xu J
    J Mol Neurosci; 2016 Aug; 59(4):567-78. PubMed ID: 27412469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway.
    Zeng Z; Wang X; Bhardwaj SK; Zhou X; Little PJ; Quirion R; Srivastava LK; Zheng W
    Mol Neurobiol; 2017 Jul; 54(5):3395-3406. PubMed ID: 27173157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
    Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.
    Chong ZZ; Hou J; Shang YC; Wang S; Maiese K
    Curr Neurovasc Res; 2011 May; 8(2):103-20. PubMed ID: 21443457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.